Juventas Therapeutics' Series B - II Round

Juventas Therapeutics raised a round of funding on November 20, 2013.

Juventas Therapeutics, formerly AcelleRx Therapeutics, Juventas Therapeutics is a privately held, clinical stage biotechnology company focused on developing non-viral gene therapies to treat advanced …

Articles about Juventas Therapeutics' Series B - II Round: